Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease

Abstract Background This study aims to determine the prevalence of impaired awareness of hypoglycemia (IAH) across all chronic kidney disease stages in patients with type 2 diabetes mellitus and to identify predictors of impaired awareness of hypoglycemia within these patients. Methods Clinical and...

Full description

Saved in:
Bibliographic Details
Main Authors: Amin Soliman, Noran Atef El Kordy, Farouk Mostafa Faris, Rabab Mahmoud Ahmed
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43162-024-00387-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585364361969664
author Amin Soliman
Noran Atef El Kordy
Farouk Mostafa Faris
Rabab Mahmoud Ahmed
author_facet Amin Soliman
Noran Atef El Kordy
Farouk Mostafa Faris
Rabab Mahmoud Ahmed
author_sort Amin Soliman
collection DOAJ
description Abstract Background This study aims to determine the prevalence of impaired awareness of hypoglycemia (IAH) across all chronic kidney disease stages in patients with type 2 diabetes mellitus and to identify predictors of impaired awareness of hypoglycemia within these patients. Methods Clinical and laboratory data were extracted from patient medical records. Participants were interviewed using validated modified Clarke’s questionnaire and Gold score to assess impaired awareness of hypoglycemia. Results Cross sectional study included 480 participants diagnosed with chronic kidney disease and type 2 diabetes. The overall prevalence of impaired awareness of hypoglycemia (IAH) was 34.6% (166 patients) according to the Clarke questionnaire and 34.4% by the Gold Score (165 patients). This prevalence varied significantly across different CKD stages, with higher rates in stage 3 (P value = 0.001). The mean impaired awareness of hypoglycemia scores were 3.98 ± 1.34 (Clarke) and 3.92 ± 1.52 (Gold), with advanced CKD stages showing statistically significant elevated scores (p value ≤ 0.05). In the 166 patients with impaired awareness of hypoglycemia, a statistically significant higher incidence of severe hypoglycemia was observed in hemodialysis patients (p value = 0.01). Most of patients with impaired awareness of hypoglycemia aged > 60 years, had more prevalent hypertension and had lower HbA1c levels (P value ≤ 0.05). However, Multivariate logistic regression analysis found that age > 60 years was a significant independent risk factor with an 8% higher risk for IAH (P = 0.01), (OR 1.08, 95% CI 1.01–1.16). Conclusion The present study is unique in investigating impaired awareness of hypoglycemia (IAH) across the full spectrum of chronic kidney disease (CKD) stages, including patients on hemodialysis. Approximately one-third of CKD patients with type 2 diabetes mellitus exhibited a general lack of awareness of hypoglycemia. Patients with stage 3 CKD showed the highest prevalence of IAH. Those already experiencing IAH and receiving hemodialysis faced more severe hypoglycemic episodes. Age over 60 years was an independent risk factor for hypoglycemia unawareness in this patient group. Larger wide scale studies are needed to further validate these results.
format Article
id doaj-art-8259e2a3b1e54b83b67988dfee4d8f09
institution Kabale University
issn 2090-9098
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj-art-8259e2a3b1e54b83b67988dfee4d8f092025-01-26T12:53:23ZengSpringerOpenThe Egyptian Journal of Internal Medicine2090-90982025-01-013711710.1186/s43162-024-00387-5Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney diseaseAmin Soliman0Noran Atef El Kordy1Farouk Mostafa Faris2Rabab Mahmoud Ahmed3Internal Medicine and Nephrology, Kasr Alainy Faculty of Medicine, Cairo UniversityInternal Medicine, Kasr Alainy Faculty of Medicine, Cairo UniversityCritical Care Medicine, Kasr Alainy Faculty of Medicine, Cairo UniversityInternal medicine and Nephrology, Kasr Alainy Faculty of medicine, Cairo UniversityAbstract Background This study aims to determine the prevalence of impaired awareness of hypoglycemia (IAH) across all chronic kidney disease stages in patients with type 2 diabetes mellitus and to identify predictors of impaired awareness of hypoglycemia within these patients. Methods Clinical and laboratory data were extracted from patient medical records. Participants were interviewed using validated modified Clarke’s questionnaire and Gold score to assess impaired awareness of hypoglycemia. Results Cross sectional study included 480 participants diagnosed with chronic kidney disease and type 2 diabetes. The overall prevalence of impaired awareness of hypoglycemia (IAH) was 34.6% (166 patients) according to the Clarke questionnaire and 34.4% by the Gold Score (165 patients). This prevalence varied significantly across different CKD stages, with higher rates in stage 3 (P value = 0.001). The mean impaired awareness of hypoglycemia scores were 3.98 ± 1.34 (Clarke) and 3.92 ± 1.52 (Gold), with advanced CKD stages showing statistically significant elevated scores (p value ≤ 0.05). In the 166 patients with impaired awareness of hypoglycemia, a statistically significant higher incidence of severe hypoglycemia was observed in hemodialysis patients (p value = 0.01). Most of patients with impaired awareness of hypoglycemia aged > 60 years, had more prevalent hypertension and had lower HbA1c levels (P value ≤ 0.05). However, Multivariate logistic regression analysis found that age > 60 years was a significant independent risk factor with an 8% higher risk for IAH (P = 0.01), (OR 1.08, 95% CI 1.01–1.16). Conclusion The present study is unique in investigating impaired awareness of hypoglycemia (IAH) across the full spectrum of chronic kidney disease (CKD) stages, including patients on hemodialysis. Approximately one-third of CKD patients with type 2 diabetes mellitus exhibited a general lack of awareness of hypoglycemia. Patients with stage 3 CKD showed the highest prevalence of IAH. Those already experiencing IAH and receiving hemodialysis faced more severe hypoglycemic episodes. Age over 60 years was an independent risk factor for hypoglycemia unawareness in this patient group. Larger wide scale studies are needed to further validate these results.https://doi.org/10.1186/s43162-024-00387-5Chronic kidney diseaseImpaired awareness of hypoglycemiaDiabetes
spellingShingle Amin Soliman
Noran Atef El Kordy
Farouk Mostafa Faris
Rabab Mahmoud Ahmed
Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
The Egyptian Journal of Internal Medicine
Chronic kidney disease
Impaired awareness of hypoglycemia
Diabetes
title Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
title_full Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
title_fullStr Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
title_full_unstemmed Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
title_short Assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
title_sort assessing prevalence and predictors of impaired awareness of hypoglycemia in type 2 diabetes patients with chronic kidney disease
topic Chronic kidney disease
Impaired awareness of hypoglycemia
Diabetes
url https://doi.org/10.1186/s43162-024-00387-5
work_keys_str_mv AT aminsoliman assessingprevalenceandpredictorsofimpairedawarenessofhypoglycemiaintype2diabetespatientswithchronickidneydisease
AT noranatefelkordy assessingprevalenceandpredictorsofimpairedawarenessofhypoglycemiaintype2diabetespatientswithchronickidneydisease
AT faroukmostafafaris assessingprevalenceandpredictorsofimpairedawarenessofhypoglycemiaintype2diabetespatientswithchronickidneydisease
AT rababmahmoudahmed assessingprevalenceandpredictorsofimpairedawarenessofhypoglycemiaintype2diabetespatientswithchronickidneydisease